Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Rank in Stocks #3556
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Share Price
$3.28
Last synced: 2026-07-31
Market Cap
$5.10B
Change (1 day)
0.00%
Change (1 year)
-49.70%
Country
TW
Trade Caliway Biopharmaceuticals Co. L (6919)

Category

Stock price history for Caliway Biopharmaceuticals Co. L (6919)
Highest end of day price: $3.30 on 2026-07-01

Lowest end of day price: $0.20 on 2022-12-01
Stock price history of Caliway Biopharmaceuticals Co. L from 2022 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -13.85%
2025 190.26%
2024 181.33%
2023 210.73%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.98 -12.73%
AU
$772.27 7.33%
CH